Position in OCUL
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$8,560,015
+$1,070,020 QoQ
Shares Held
871,692
-1.4% QoQ
Ownership
0.398%
of shares outstanding
% of Portfolio
0.60%
of 13F equity value
Holder Rank
#1
of 35 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OCUL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Empire Life Investments Inc. holds $27,170,981 across 5 Biotechnology names. OCUL ranks #2 (31.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LEGN |
Legend Biotech Corp
|
296,586 | $8,565,403 | |
| 2 | OCUL |
Ocular Therapeutix, Inc
This page
|
871,692 | $8,560,015 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
12,640 | $3,805,019 | |
| 4 | SPRY |
ARS Pharmaceuticals, Inc.
|
471,856 | $3,779,566 | |
| 5 | ARCT |
Arcturus Therapeutics Holdings Inc.
|
366,217 | $2,460,978 |
All Filings in OCUL
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,560,015 | 871,692 | Shares | Defined | 2026-07-24 | |
| 2026-03-31 | $7,489,995 | 884,297 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $6,556,996 | 540,115 | Shares | Defined | 2026-02-04 | |
| 2025-09-30 | $2,937,252 | 251,262 | Shares | Defined | 2025-11-12 | |
| No filing history on record for this holder in this stock. | ||||||